Join
Live feed
·
INSIDERFilingvia Quantisnow
Viridian Therapeutics Inc. logo

SEC Form 4: Meisner Lara sold $871,257 worth of shares (29,971 units at $29.07) as part of a pre-agreed trading plan, closing all direct ownership in the company

ByQuantisnow·Wall Street's wire, on your screen.
VRDN· Viridian Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VRDN (Viridian Therapeutics Inc.) and more on Quantisnow.